Jan Malik

Jan Malik

Auto-generated profile, based on publicly available information

Jan Malik

Department of Zoology and Fisheries, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Food Chemistry
Verified
Journal Article
Closed access
JMJan Malik
Jan Malik
JSJiřina Száková
Jiřina Száková
ODOndrej Drabek
Ondrej Drabek
JBJiri Balik
Jiri Balik
Ladislav KokoskaLadislav Kokoska
Ladislav Kokoska

1 August 2013 in Food Chemistry
Verified
Journal Article
Closed access
JMJan Malik
Jan Malik
AFAdela University of Life Sciences - Adéla Frankova
Adela University of Life Sciences - Adéla Frankova
ODOndrej Drabek
Ondrej Drabek
JSJiřina Száková
Jiřina Száková
CAChristopher Ash
Christopher Ash
Ladislav KokoskaLadislav Kokoska
Ladislav Kokoska

3 March 2010 in Molecules
Verified
Journal Article
Open access
PDF file
OSOlga Sklenickova
Olga Sklenickova
JFJaroslav Flesar
Jaroslav Flesar
Ladislav KokoskaLadislav Kokoska
Ladislav Kokoska
EVEva Vlkova
Eva Vlkova
KHKaterina Halamova
Katerina Halamova
JMJan Malik
Jan Malik
Both bifidobacteria and clostridia are part of the natural gut microflora and while clostridia may be responsible for severe intestinal infections, bifidobacteria are probiotic microorganisms belonging to the most important prospective bacteria in the bowel. The antimicrobial activity of biochanin A was tested in vitro against six Bifidobacterium spp., and eight Clostridium spp. using the broth microdilution method. Biochanin A showed an inhibition against all clostridia in the range of minimum inhibitory concentrations (MIC) from 64 μg/mL (for Cl. clostridioforme, strains DSM 933 and I3) to 1,024 μg/mL (for Cl. perfringens, DSM 11778). No bifidobacteria were suppressed at four-fold higher concentration (MICs > 4,096) than MIC of Cl. perfringens. These results indicate selective growth inhibition of biochanin A and its potential use in antimicrobial prevention and/or protection.

15 December 2011 in Planta Medica
Verified
Journal Article
Closed access
PDF file
PLPremysl Landa
Premysl Landa
ZKZsofia Kutil
Zsofia Kutil
VTVeronika Sophie Temml
Veronika Sophie Temml
AVAnna Vuorinen
Anna Vuorinen
JMJan Malik
Jan Malik
TVTomas Vanek
Tomas Vanek
In this study, ten anthra-, nine naphtho-, and five benzoquinone compounds of natural origin and five synthetic naphthoquinones were assessed, using an enzymatic in vitro assay, for their potential to inhibit cyclooxygenase-1 and -2 (COX-1 and COX-2), the key enzymes of the arachidonic acid cascade. IC50 values comparable with COX reference inhibitor indomethacin were recorded for several quinones (primin, alkannin, diospyrin, juglone, 7-methyljuglone, and shikonin). For some of the compounds, we suggest the redox potential of quinones as the mechanism responsible for in vitro COX inhibition because of the quantitative correlation with their pro-oxidant effect. Structure-relationship activity studies revealed that the substitutions at positions 2 and 5 play the key roles in the COX inhibitory and pro-oxidant actions of naphthoquinones. In contrast, the redox mechanism alone could not explain the activity of primin, embelin, alkannin, and diospyrin. For these four quinones, molecular modeling suggested similar binding modes as for conventional nonsteroidal anti-inflammatory drugs (NSAIDs).

17 January 2012 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
PDF file
Ladislav KokoskaLadislav Kokoska
Ladislav Kokoska
KUKlara Urbanova
Klara Urbanova
PKPavel Klouček
Pavel Klouček
LNLenka Nedorostova
Lenka Nedorostova
LPLucie Polesna
Lucie Polesna
IVIrena Valterova
Irena Valterova

1 January 2013 in Natural Product Communications
Verified
Journal Article
Open access
PDF file
PLPremysl Landa
Premysl Landa
ZKZsofia Kutil
Zsofia Kutil
VTVeronika Sophie Temml
Veronika Sophie Temml
JMJan Malik
Jan Malik
LKLadislav Kokoska
Ladislav Kokoska
TVTomas Vanek
Tomas Vanek
Quinones are compounds frequently contained in medicinal plants used for the treatment of inflammatory diseases. Therefore, the impact of plant-derived quinones on the arachidonic acid metabolic pathway is worthy of investigation. In this study, twenty-three quinone compounds of plant origin were tested in vitro for their potential to inhibit leukotriene B4 (LTB4) biosynthesis in activated human neutrophil granulocytes with 5-lipoxygenase (5-LOX) activity. The benzoquinones primin (3) and thymohydroquinone (4) (IC50 = 4.0 and 4.1 μM, respectively) showed activity comparable with the reference inhibitor zileuton (IC50 = 4.1 μM). Moderate activity was observed for the benzoquinone thymoquinone (2) (IC50 = 18.2 μM) and the naphthoquinone shikonin (1) (IC50 = 24.3 μM). The anthraquinone emodin and the naphthoquinone plumbagin (5) displayed only weak activities (IC50 > 50 μM). The binding modes of the active compounds were further evaluated in silico by molecular docking to the human 5-LOX crystal structure. This process supports the biological data and suggested that, although the redox potential is responsible for the quinone's activity on multiple targets, in the case of 5-LOX the molecular structure plays a vital role in the inhibition. The obtained results suggest primin as a promising compound for the development of dual COX-2/5-LOX inhibitors.